Equities

Kimia Farma Tbk PT

KAEF:JKT

Kimia Farma Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)925.00
  • Today's Change-5.00 / -0.54%
  • Shares traded333.70k
  • 1 Year change-46.84%
  • Beta-0.5372
Data delayed at least 10 minutes, as of Mar 31 2023 09:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing pharmaceutical products, such as medicines, active pharmaceutical ingredients, traditional medicines, and cosmetics. The Company produces medical devices and chemical materials. The Company is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.

  • Revenue in IDR (TTM)10.50tn
  • Net income in IDR-180.60bn
  • Incorporated1971
  • Employees11.51k
  • Location
    Kimia Farma Tbk PTJalan Veteran No. 9JAKARTA 10110IndonesiaIDN
  • Phone+62 213847709
  • Fax+62 213814441
  • Websitehttp://www.kimiafarma.co.id
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Merck Tbk PT1.15tn163.62bn2.15tn393.0013.172.9711.341.88365.22365.222,561.491,621.141.222.168.412,980,644,000.0017.457.2221.6910.9137.7839.0414.269.531.9234.450.0235426.2262.290.565483.11-3.0711.07-2.69
Indofarma Tbk PT2.31tn-223.52bn2.18tn1.18k--6.72--0.9463-72.15-72.15745.51104.921.116.055.691,842,803,000.00-10.77-1.40-23.64-2.791.3517.81-9.68-1.180.9242-3.140.5993--69.1511.62-136,356.00---18.53--
Darya-Varia Laboratoria Tbk PT1.86tn43.95bn2.21tn1.26k50.321.5220.611.1939.2539.251,657.991,300.030.87192.222.661,498,745,000.002.069.982.7213.5252.3353.532.3710.132.18--0.001867.953.895.54-9.47-0.7147-14.9911.89
Kimia Farma Tbk PT10.50tn-180.60bn5.17tn11.51k--0.716519.740.4928-32.52-32.521,890.121,297.920.55982.194.54881,718,000.00-1.011.82-1.643.0033.8536.28-1.802.550.59650.54040.549224.7928.5017.211,613.682.4812.1411.14
Tempo Scan Pacific Tbk PT11.98tn818.70bn6.29tn4.55k7.620.91965.510.5252183.00183.002,679.311,516.931.184.349.262,535,298,000.008.488.3311.5111.4634.2637.207.166.441.85--0.160436.322.434.224.578.96-0.12376.96
Soho Global Health Tbk PT6.89tn325.04bn6.60tn2.41k20.302.6516.780.9574256.10256.105,431.661,963.831.524.704.872,875,966,000.007.15--12.94--18.72--4.72--1.46--0.0108--14.80--219.67------
PT Industri Jamu dan Farmasi Sd Mncl Tbk3.87tn1.10tn25.20tn3.17k22.797.1920.796.5236.8536.85128.85116.850.94863.415.721,220,948,000.0027.1125.9231.2729.5455.9555.0828.5827.983.05--0.000793.06-3.878.47-12.3915.66-12.1820.46
Data as of Mar 31 2023. Currency figures normalised to Kimia Farma Tbk PT's reporting currency: Indonesian Rupiah IDR
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.